Product Information
METFORMIN HCL ER 500 MG TABLET is a generic product labeled by Time-Cap Labs Inc., priced at $0.0284 per EA under NDC 49483062309. Its NADAC has been published 418 times since Oct 3, 2018.
FDA first approved this application on Apr 29, 2016. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Time-Cap Labs Inc.NDC
49483062309
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090295FDA Approved
4/29/2016
TE Code
AB1
On Market Since
5/12/2016
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL ER 500 MG TABLET has been published 418 times since Oct 3, 2018, and over the history we have for it it has declined 14.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0284 per EA |
|---|---|
| All-time high | $0.0445 (Nov 16, 2022) |
| All-time low | $0.0238 (Nov 20, 2024) |
| 52-week high | $0.0299 |
| 52-week low | $0.0284 |
| Median price | $0.0340 |
| Average price | $0.0337 |
| Largest weekly change | +29.1% (Feb 22, 2023) |
| Weeks tracked | 418 |
| Tracking since | Oct 3, 2018 |
Generic Alternatives
The matcher finds 21 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Time-Cap Labs Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metformin Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Biguanide class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METFORMIN HCL ER 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL ER 500 MG TABLET, manufactured by Time-Cap Labs Inc., is $0.0284 per EA (NDC 49483062309), effective Sep 30, 2026.
How has the price of METFORMIN HCL ER 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL ER 500 MG TABLET has declined 14.0%. It has been tracked across 418 weekly CMS publications since Oct 3, 2018.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL ER 500 MG TABLET?
Since Oct 3, 2018, the NADAC for METFORMIN HCL ER 500 MG TABLET has ranged from a low of $0.0238 (Nov 20, 2024) to a high of $0.0445 (Nov 16, 2022), with a median of $0.0340 per EA.
Are there cheaper alternatives to METFORMIN HCL ER 500 MG TABLET?
Yes. 21 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METFORMIN HCL 500 MG TABLET, is $0.0145 per EA — about 49% below METFORMIN HCL ER 500 MG TABLET.
Who manufactures METFORMIN HCL ER 500 MG TABLET?
METFORMIN HCL ER 500 MG TABLET (NDC 49483062309) is labeled by Time-Cap Labs Inc., and CMS classifies it as a generic product.